SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Immatics Presents Clinical Activity of Two PRAME Therapies at 2026 ESMO Meeting

Immatics says it will present clinical activity of IMA402 and IMA203CD8 in advanced solid tumors in two oral presentations at the 2026 ESMO Annual Meeting.

IMTX

Related stories